Venrock Adviser, LLC
Venrock Adviser, LLC reported 34 positions worth $2.06B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ORKA (16.8%). Biggest move: exit APOGEE THERAPEUTICS INC ($1.13B).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | ORKA | $345.5M | 16.79% | 4,148,428 | — | — | +19.1% | |
| ▸ 2 | ERAS | $294.5M | 14.31% | 20,089,932 | — | — | — | |
| ▸ 3 | SYRE | $221.3M | 10.75% | 2,485,448 | — | — | +16.8% | |
| ▸ 4 | KRSA | $145.6M | 7.07% | 4,549,585 | — | — | — | |
| ▸ 5 | SVRA | $101.0M | 4.91% | 19,568,534 | — | — | -10.1% | |
| ▸ 6 | OCUL | $79.4M | 3.86% | 10,346,926 | — | — | -21.6% | |
| ▸ 7 | DMRA | $76.7M | 3.73% | 3,603,595 | — | — | +1.5% | |
| ▸ 8 | DNTH | $72.4M | 3.52% | 822,020 | — | — | +1.7% | |
| ▸ 9 | VRDN | $67.1M | 3.26% | 3,257,917 | — | — | +49.9% | |
| ▸ 10 | VOR | $58.0M | 2.82% | 3,041,719 | — | — | -0.6% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Venrock Adviser, LLC hold as of Q3 2026?
Venrock Adviser, LLC reported 34 positions worth $2.06B in its Q3 2026 13F filing. Largest positions: ORKA (16.8%), ERAS (14.3%), SYRE (10.8%), KRSA (7.1%) and SVRA (4.9%).
What did Venrock Adviser, LLC buy in Q3 2026?
New positions: KRSA, DMRA, ADRX, ARVN and ENTERA BIO LTD (7 in all). Added to: ERAS, SVRA, ACHV, XFOR and RLMD (7 in all).
What did Venrock Adviser, LLC sell in Q3 2026?
Reduced: SYRE, DNTH, ORIC, KRRO and MAZE. Sold out entirely: APOGEE THERAPEUTICS INC , DAMORA THERAPEUTICS INC , ELVN, HELP and CTMX (6 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.